MyFinsight
Home
Blog
About
Contact
Download
Download image
Net income (loss)
$287,202K
Amortization and
depreciation
$19,449K
Share-based compensation
$14,678K
Foreign exchange loss
(gain) on revaluation...
-$9,685K
Prepaid expenses and
other current assets
-$5,522K
Deferred revenue
$3,668K
Other noncurrent
operating assets
-$730K
Cash flows from
operating activities
$135,658K
Canceled cashflow
$205,276K
Net (decrease)
increase in cash, cash...
-$3,220K
Canceled cashflow
$135,658K
Proceeds from issuance of
common shares from...
$14,190K
Proceeds from issuance of
common shares under...
$756K
Proceeds from the sale and
maturities of investments
$494,134K
Deferred income tax
benefit
-$176,194K
Net amortization of
premiums and discounts on...
$10,179K
Inventory
$6,462K
Accounts receivable, net
$4,910K
Accrued expenses and
other liabilities
-$4,655K
Accounts payable
-$1,874K
Operating lease
liabilities
-$802K
Other, net
$200K
Cash flows from
financing activities
-$106,110K
Canceled cashflow
$14,946K
Cash flows from
investing activities
-$32,768K
Canceled cashflow
$494,134K
Repurchase of common shares
$98,156K
Principal portion of
finance lease payments
$13,136K
Taxes paid related to
net settlement of...
$9,764K
Purchases of investments
$526,650K
Purchases of property,
equipment and intangible...
$252K
Back
Back
Cash Flow
source: myfinsight.com
Aurinia Pharmaceuticals Inc. (AUPH)
Aurinia Pharmaceuticals Inc. (AUPH)